Tang Capital Management’s Journey Medical DERM Stock Holding History

Tang Capital Management’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.4M	Hold	1,610,000	–	–	0.52%	30
2026 Q1	$7.55M	Sell	1,610,000 -244,596	-13%	-$1.9M	0.38%	30
2025 Q4	$14.3M	Hold	1,854,596	–	–	0.71%	32
2025 Q3	$13.2M	Hold	1,854,596	–	–	0.51%	49
2025 Q2	$13.3M	Hold	1,854,596	–	–	0.67%	42
2025 Q1	$10.9M	Buy	1,854,596 +129,027	+7%	+$634K	0.61%	44
2024 Q4	$6.75M	Buy	+1,725,569	New	+$9.43M	0.45%	62
2024 Q3	–	Sell	-148,322	Closed	-$837K	–	158
2024 Q2	$837K	Buy	148,322 +9,697	+7%	+$39.9K	0.09%	98
2024 Q1	$510K	Buy	+138,625	New	+$603K	0.05%	94
2023 Q4	–	Sell	-576,100	Closed	-$1.58M	–	126
2023 Q3	$1.58M	Buy	+576,100	New	+$1.29M	0.22%	77

Other funds holding DERM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PAIM

Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return

PFCS

Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Tang Capital Management's DERM Position: Q2 2026 in Review

Tang Capital Management held its Journey Medical (DERM) position steady in Q2 2026 at 1,610,000 shares worth $11.4M. The position accounts for 0.52% of the portfolio, ranked #30.

Tang Capital Management first reported a position in DERM in Q3 2023 and has held it in 10 quarters since. The position peaked at $14.3M in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

Tang Capital Management held 1,610,000 shares of Journey Medical worth $11.4M as of Q2 2026.
Tang Capital Management left its Journey Medical share count unchanged in Q2 2026.
Journey Medical made up 0.52% of Tang Capital Management's portfolio in Q2 2026, its #30 holding.
Tang Capital Management first reported a position in Journey Medical in Q3 2023 and has held it in 10 quarters since.
Tang Capital Management's Journey Medical position peaked at $14.3M in Q4 2025.
71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Tang Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.